Download PDFPDF
Antidepressants for neuropathic pain: a Cochrane review
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Prevention versus treatment of postherpetic neuralgia
    • Josephine M.I. Vos, internist-haematologist in training
    • Other Contributors:
      • Prof.dr. S. Middeldorp

    Amsterdam, 4th May 2011

    Dear dr. Saarto,

    Regarding your Cochrane review "Antidepressants for neuropathic pain" which was published in J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1372 -3, we would like to point out an inconsistency.

    Our comment refers to the statement made on page 11: : "Six placebo- controlled studies were found in postherpetic neuralgia. All demonstrated superiority of a...

    Show More
    Conflict of Interest:
    None declared.